Optic nerve sheath meningioma

Summary

Optic nerve sheath meningioma (MONDO:0003557) is a disease. A subtype of optic nerve neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	optic nerve sheath meningioma
Mondo ID	MONDO:0003557
DOID	DOID:5632
NCIT	C4538
SNOMED CT	254978007
UMLS	C0346328
MedGen	138057
GARD	0023563
Is cancer (heuristic)	no

Also known as: meningioma of optic nerve sheath · meningioma of the optic nerve sheath · optic nerve sheath meningioma

Disease family

This is a subtype of optic nerve neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › optic nerve disorder › optic nerve neoplasm › optic nerve sheath meningioma

Related subtypes (2): optic nerve glioma, bilateral meningioma of optic nerve

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.